AI-generated summary
This prospective case series followed patients taking antiresorptive drugs who needed oral surgery, using photonic protocols (antimicrobial photodynamic therapy and photobiomodulation) to prevent or treat medication-related osteonecrosis of the jaws. The authors report that none of 18 patients given the preventive protocol developed signs of the condition over at least 6 months, and 16 of 17 treated patients showed total lesion regression. The authors describe these protocols as appearing effective as adjuvant approaches.
- Who or what was studied
- Patients exposed to antiresorptive drugs who required oral surgery, including those with medication-related osteonecrosis of the jaws
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The abstract describes a small prospective case series with no control group and follow-up of at least 6 months, so certainty of benefit is limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
- Energy density (fluence)
- 321 J/cm2
- Power
- 0.1 W
- Total energy
- 9 J, 27J, 3 J, 12 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Photodynamic therapy, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.